Treace Medical Concepts (TMCI) EBIAT (2020 - 2025)
Historic EBIAT for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$16.3 million.
- Treace Medical Concepts' EBIAT fell 604.17% to -$16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.1 million, marking a year-over-year increase of 1855.24%. This contributed to the annual value of -$55.7 million for FY2024, which is 1255.07% down from last year.
- According to the latest figures from Q3 2025, Treace Medical Concepts' EBIAT is -$16.3 million, which was down 604.17% from -$17.4 million recorded in Q2 2025.
- Treace Medical Concepts' EBIAT's 5-year high stood at -$501000.0 during Q4 2024, with a 5-year trough of -$21.2 million in Q2 2024.
- Its 5-year average for EBIAT is -$11.5 million, with a median of -$12.3 million in 2023.
- Per our database at Business Quant, Treace Medical Concepts' EBIAT plummeted by 35784.96% in 2021 and then skyrocketed by 9202.36% in 2024.
- Quarter analysis of 5 years shows Treace Medical Concepts' EBIAT stood at -$6.6 million in 2021, then soared by 33.34% to -$4.4 million in 2022, then tumbled by 42.36% to -$6.3 million in 2023, then surged by 92.02% to -$501000.0 in 2024, then plummeted by 3151.1% to -$16.3 million in 2025.
- Its EBIAT was -$16.3 million in Q3 2025, compared to -$17.4 million in Q2 2025 and -$15.9 million in Q1 2025.